Cardio-oncology has organically developed as a new discipline within cardiovascular
medicine as a result of the cardiac and vascular adverse sequelae of the major advances in …

A considerable body of evidence exists suggesting a link among reduced testosterone
plasma levels, type 2 diabetes (T2D), and insulin resistance (IR). Hypogonadal men are at …

Objective Men with the metabolic syndrome (MetS) have low plasma testosterone (T) levels.
The aim of this study was to establish whether the normalization of plasma T improves the …

Androgen‐deprivation therapy (ADT) is a common treatment for men with prostate cancer.
Although ADT is effective at suppressing prostate‐specific antigen (PSA), stabilizing …

Testosterone deficiency (TD) afflicts approximately 30% of men aged 40-79 years, with an
increase in prevalence strongly associated with aging and common medical conditions …

Obesity, metabolic syndrome, and type 2 diabetes (T2D) are related disorders with
widespread deleterious effects throughout the body. One important target of damage is the …

A considerable body of evidence exists suggesting that androgen deficiency contributes to
the onset, progression, or both of cardiovascular disease (CVD). The aim of this review is to …

It is becoming increasingly evident that the low serum levels of testosterone experienced by
aging men are associated with increased all-cause mortality from CHD and other vascular …

A significant proportion of patients with type 2 diabetes mellitus have a low testosterone
level relative to reference ranges based on healthy young men. Only a small number of …

Testosterone is important in the physiology of various organs and tissues. The serum
testosterone concentration gradually declines as one of the processes of aging. Thus, the …